Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Recommendation of "Moderate Buy" by Analysts

Key Points

• Analysts collectively rate Merit Medical Systems “Moderate Buy.” Of 12 analysts, eight recommend buying, one gives a strong-buy rating, and three recommend holding; the average 12-month price target is $100, compared with a recent price of $90.68.
• Recent quarterly results exceeded expectations. Merit reported adjusted EPS of $1.19 versus the $0.96 consensus estimate and revenue of $418.84 million versus $405.25 million, with year-over-year revenue growth of 9.5%.
• Institutional ownership is substantial, at 99.66%. Several funds added or initiated positions during the second quarter, including California State Teachers Retirement System, which dramatically increased its stake.

Merit Medical Systems, Inc. (NASDAQ:MMSI - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve analysts that are covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $100.00.

MMSI has been the topic of several research reports. Wells Fargo & Company raised their price target on Merit Medical Systems from $74.00 to $83.00 and gave the company an "equal weight" rating in a research note on Friday, July 31st. Bank of America upped their price objective on shares of Merit Medical Systems from $92.00 to $97.00 and gave the stock a "neutral" rating in a research note on Thursday, August 13th. JPMorgan Chase & Co. increased their target price on shares of Merit Medical Systems from $77.00 to $95.00 and gave the stock an "overweight" rating in a report on Friday, July 31st. Piper Sandler boosted their price target on shares of Merit Medical Systems from $96.00 to $106.00 and gave the company an "overweight" rating in a report on Friday, July 31st. Finally, Canaccord Genuity Group upped their price target on shares of Merit Medical Systems from $85.00 to $94.00 and gave the stock a "buy" rating in a research report on Friday, July 31st.

Institutional Trading of Merit Medical Systems

A number of hedge funds have recently bought and sold shares of MMSI. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Merit Medical Systems during the 2nd quarter valued at $673,000. California State Teachers Retirement System raised its position in shares of Merit Medical Systems by 6,636.5% in the 2nd quarter. California State Teachers Retirement System now owns 4,682,184 shares of the medical instruments supplier's stock worth $324,663,000 after acquiring an additional 4,612,679 shares in the last quarter. Irenic Capital Management LP bought a new position in shares of Merit Medical Systems in the 2nd quarter worth $37,623,000. BAM Wealth Management LLC lifted its stake in shares of Merit Medical Systems by 56.6% during the 2nd quarter. BAM Wealth Management LLC now owns 6,541 shares of the medical instruments supplier's stock worth $454,000 after purchasing an additional 2,365 shares during the last quarter. Finally, iSAM Funds UK Ltd purchased a new stake in shares of Merit Medical Systems during the 2nd quarter worth $222,000. Hedge funds and other institutional investors own 99.66% of the company's stock.

Merit Medical Systems Stock Performance

Shares of NASDAQ:MMSI opened at $90.68 on Wednesday. The firm's 50 day simple moving average is $80.72 and its 200-day simple moving average is $72.98. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20. Merit Medical Systems has a one year low of $59.74 and a one year high of $94.75. The firm has a market cap of $5.41 billion, a PE ratio of 37.47, a price-to-earnings-growth ratio of 2.26 and a beta of 0.49.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.23. The firm had revenue of $418.84 million during the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.Merit Medical Systems's quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities analysts predict that Merit Medical Systems will post 3.84 EPS for the current year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source